Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Influenza Virus Research Studies, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, and Immune Response and Inflammation.
Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA
Broadly neutralizing antibodies target a haemagglutinin anchor epitope
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine**
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus
A serological assay to detect SARS-CoV-2 seroconversion in humans
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Human germinal centres engage memory and naive B cells after influenza vaccination
Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice
Broadly protective human antibodies that target the active site of influenza virus neuraminidase
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus